amiodarone has been researched along with Morbid Obesity in 4 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Michel, C | 1 |
| Hecq, JD | 1 |
| Bertrand, C | 1 |
| Spinewine, A | 1 |
| Minhaj, MM | 1 |
| Zvara, DA | 1 |
| Nayyar, P | 1 |
| Maslow, A | 1 |
| Bourron, O | 1 |
| Ciangura, C | 1 |
| Bouillot, JL | 1 |
| Massias, L | 1 |
| Poitou, C | 1 |
| Oppert, JM | 1 |
| Louis, R | 1 |
| Melon, P | 1 |
| Kassab, A | 1 |
| Soyeur, D | 1 |
4 other studies available for amiodarone and Morbid Obesity
| Article | Year |
|---|---|
[Clinical pharmacist intercepts iatrogenic event through medication reconciliation: a case report].
Topics: Amiodarone; Anti-Arrhythmia Agents; Appendicitis; Belgium; Digoxin; Drug Information Services; Human | 2013 |
Case 1-2007 morbidly obese patient undergoing cardiac surgery.
Topics: Amiodarone; Anesthesia, General; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Catheterizatio | 2007 |
Amiodarone-induced hyperthyroidism during massive weight loss following gastric bypass.
Topics: Amiodarone; Anti-Arrhythmia Agents; Gastric Bypass; Humans; Hyperthyroidism; Male; Middle Aged; Obes | 2007 |
[How I treat...persistent atrial fibrillation, by internal cardioversion, in a patient with exreme obesity].
Topics: Alcoholism; Amiodarone; Anti-Arrhythmia Agents; Anticoagulants; Atrial Fibrillation; Body Mass Index | 2001 |